A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in nave and infection-primed mice

By Ruitenberg K.M.   Walker C.   Love D.N.   Wellington J.E.   Whalley J.M.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1367-1373

Elsevier

Access to resources Recommend Favorite

Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine

By Studdert M.J.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 992-992

Elsevier

Access to resources Recommend Favorite

Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization

By Deshpande M.S.   Ambagala T.C.   Hegde N.R.   Hariharan M.J.   Navaratnam M.   Srikumaran S.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3744-3751

Elsevier

Access to resources Recommend Favorite

Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV 1,4 ). Vaccination/challenge experiments in foals and pregnant mares

By Heldens J.G.M.   Hannant D.   Cullinane A.A.   Prendergast M.J.   Mumford J.A.   Nelly M.   Kydd J.H.   Weststrate M.W.   van den Hoven R.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4307-4317

Elsevier

Access to resources Recommend Favorite

Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme

By Huemer H.P.   Strobl B.   Nowotny N.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1320-1326

Elsevier

Access to resources Recommend Favorite